October 15, 2020 10:13 AM EDT

Eli Lilly bags an early-stage biotech for the neuro team — paying $135M cash and offering $1B-plus in milestones

Eli Lilly is snapping up a little Cambridge-based biotech to add to their neuro group.

The pharma giant is

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Eli Lil­ly bags an ear­ly-stage biotech for the neu­ro team — pay­ing $135M cash and of­fer­ing $1B-plus in mile­stones